Vipul R. Patel, MD, FACS, is a board-certified urologic surgeon, medical director of the Global Robotics Institute at AdventHealth, and medical director of urologic oncology at AdventHealth Cancer ...
To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...
About 1 in 8 men will be diagnosed with prostate cancer in their lifetime The average age at diagnosis is 67 Less than 1% of the 3.5 million men living with prostate cancer are expected to die from it ...
In an interview, Dr. David A. Taub highlighted Prostate Cancer Awareness Month by outlining current treatment options for patients with prostate cancer. In an interview with CURE, Dr. David A. Taub ...
AMPLIFY: A phase 3 study of 64Cu-SAR-bisPSMA positron emission tomography in participants with biochemical recurrence of prostate cancer. SOLACE: A phase 1 pharmacokinetic, dosimetry, safety, and dose ...
An updated Cochrane review has concluded there is evidence that PSA screening reduces prostate cancer deaths. The analysis of 800,000 men aged 50 to 74 years who took part in large trials across ...
Risk factors are things that raise your chances of getting a disease. For each person, there’s a mix of genetic, biological and lifestyle factors that play a part in prostate cancer risk. About 1 in ...
For men with advanced prostate cancer that no longer responds to standard hormone therapies, treatment options are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results